|
Recent Newsletters
Week in Review: Patient injuries lead to recall | SAVR bests TAVR | Key takeaways from AHA 2024 | FDA clears AI screening tool |
Week in Review: Payment cuts & beyond | Isotope shortage may be over | TAVR valves after 5 years | Fraud lands doc in prison |
Week in Review: Higher payments for CCTA | Lessons from EARLY TAVR | FDA approves another PFA system |
October's Top Stories: FDA’s tirzepatide decision | Compensation rises | TAVR survival dips | Why are there so many recalls? |
Week in Review: FDA approves all-in-one PFA system | TAVR for asymptomatic AS | Cardiologist gets life in prison |
test newsletter extra space? |
Week in Review: New CPT code for AI software | Why are device recalls so common? | Heart surgeon compensation rises |